Literature DB >> 22175058

Update on anal fistulae: surgical perspectives for the gastroenterologist.

Helena Tabry1, Paul A Farrands.   

Abstract

Anal fistulae are common and debilitating; they are characterized by severe pain and discharge. They arise following infection near the anal canal, or as a primary event from an abscess in the abdomen, fistulating into the vagina or perianal skin. The term 'cryptoglandular' is given to abscesses arising from the anal glands.For many years, the treatment of choice was to lay open the fistula; however, this risks causing incontinence with potentially devastating consequences. Alternative surgical treatments include setons, fibrin glue, collagen plugs and flaps to cover the internal fistula opening. These have achieved varying degrees of success, as will be discussed. The present review also discusses anal fistulae in light of much recently published literature. Currently, anal fistulae remain challenging and require specialist expertise; however, new treatment options are on the horizon.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22175058      PMCID: PMC3266159          DOI: 10.1155/2011/931316

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  42 in total

Review 1.  Review article: medical, surgical and radiological management of perianal Crohn's fistulas.

Authors:  P J Tozer; D Burling; A Gupta; R K S Phillips; A L Hart
Journal:  Aliment Pharmacol Ther       Date:  2010-10-29       Impact factor: 8.171

2.  Local injection of Infliximab for the treatment of perianal Crohn's disease.

Authors:  G Poggioli; S Laureti; F Pierangeli; F Rizzello; F Ugolini; P Gionchetti; M Campieri
Journal:  Dis Colon Rectum       Date:  2005-04       Impact factor: 4.585

3.  Modified loose-seton technique for the treatment of complex anal fistulas.

Authors:  George Pinedo M; Gino Caselli M; Gonzalo Urrejola S; Sergio Niklitschek L; María Elena Molina P; Felipe Bellolio R; Alvaro Zúñiga D
Journal:  Colorectal Dis       Date:  2010-10       Impact factor: 3.788

4.  A randomized, controlled trial of fibrin glue vs. conventional treatment for anal fistula.

Authors:  Ian Lindsey; M M Smilgin-Humphreys; Chris Cunningham; Neil J M Mortensen; Bruce D George
Journal:  Dis Colon Rectum       Date:  2002-12       Impact factor: 4.585

Review 5.  Incontinence rates after cutting seton treatment for anal fistula.

Authors:  R D Ritchie; J M Sackier; J P Hodde
Journal:  Colorectal Dis       Date:  2008-10-17       Impact factor: 3.788

6.  Management of idiopathic anal fistula using cross-linked collagen: a prospective phase 1 study.

Authors:  T M Hammond; T R Porrett; S M Scott; N S Williams; P J Lunniss
Journal:  Colorectal Dis       Date:  2011-01       Impact factor: 3.788

7.  A novel material in seton treatment of fistula-in-ano.

Authors:  Ahmet Gurer; Nuraydin Ozlem; Ali Kagan Gokakin; Mehmet Ozdogan; Hakan Kulacoglu; Raci Aydin
Journal:  Am J Surg       Date:  2007-06       Impact factor: 2.565

8.  Endorectal advancement flaps in the treatment of high anal fistula of cryptoglandular origin: full-thickness vs. mucosal-rectum flaps.

Authors:  Peter C Dubsky; Anton Stift; Josef Friedl; Bela Teleky; Friedrich Herbst
Journal:  Dis Colon Rectum       Date:  2008-03-04       Impact factor: 4.585

9.  Fibrin glue in the treatment of anal fistula: a systematic review.

Authors:  Roberto Cirocchi; Eriberto Farinella; Francesco La Mura; Lorenzo Cattorini; Barbara Rossetti; Diego Milani; Patrizia Ricci; Piero Covarelli; Marco Coccetta; Giuseppe Noya; Francesco Sciannameo
Journal:  Ann Surg Innov Res       Date:  2009-11-14

10.  Gracilis muscle interposition for the treatment of recto-urethral and rectovaginal fistulas: a retrospective analysis of 35 cases.

Authors:  Dietmar Ulrich; Joachim Roos; Gerhard Jakse; Norbert Pallua
Journal:  J Plast Reconstr Aesthet Surg       Date:  2009-01-21       Impact factor: 2.740

View more
  8 in total

1.  Comparison of different magnetic resonance imaging sequences for assessment of fistula-in-ano.

Authors:  Michael R Torkzad; Håkan Ahlström; Urban Karlbom
Journal:  World J Radiol       Date:  2014-05-28

2.  An open prospective study evaluating efficacy and safety of a new medical device for rectal application of activated carbon in the treatment of chronic, uncomplicated perianal fistulas.

Authors:  Antoni Zawadzki; Louis Banka Johnson; Måns Bohe; Claes Johansson; Mats Ekelund; Ole Haagen Nielsen
Journal:  Int J Colorectal Dis       Date:  2016-11-23       Impact factor: 2.571

Review 3.  Factors Increasing the Risk of Recurrence in Fistula-in-ano.

Authors:  Nabiyah Bakhtawar; Muhammad Usman
Journal:  Cureus       Date:  2019-03-07

4.  Efficacy of flap repair for anal fistula: study protocol for a systematic review of randomized controlled trial.

Authors:  Hao Zhang; Tao Xu; Xiao-Dong Zhang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

5.  Therapeutic management of complex anal fistulas by installing a nitinol closure clip: study protocol of a multicentric randomised controlled trial--FISCLOSE.

Authors:  Anne Dubois; Guillaume Carrier; Bruno Pereira; Brigitte Gillet; Jean-Luc Faucheron; Denis Pezet; David Balayssac
Journal:  BMJ Open       Date:  2015-12-16       Impact factor: 2.692

Review 6.  Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive-a Laboratory and Clinical Perspective.

Authors:  William D Spotnitz
Journal:  ISRN Surg       Date:  2014-03-04

7.  Fistula-in-Ano Complicated by Fournier's Gangrene Our Experience in North-Eastern Region of Nigeria.

Authors:  Abubakar A Bakari; Nuhu Ali; Ibrahim A Gadam; Bata M Gali; Chubado Tahir; Kdt Yawe; Adamu B Dahiru; Baba S Mohammed; Dauda Wadinga
Journal:  Niger J Surg       Date:  2013-07

8.  Diagnostic performance of intravoxel incoherent motion diffusion-weighted imaging and dynamic contrast-enhanced MRI for assessment of anal fistula activity.

Authors:  Philippe Lefrançois; Mathieu Zummo-Soucy; Damien Olivié; Jean-Sébastien Billiard; Guillaume Gilbert; Juliette Garel; Emmanuel Visée; Perrine Manchec; An Tang
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.